Cancer Letters
28 September 2018
Pyrazolo[1,5-a]pyrimidine TRPC6 antagonists for the treatment of gastric cancer
Mingmin Dinga,d,1, Hongbo Wangb,1, Chunrong Qua,d,1, Fuchun Xua,1, Yingmin Zhuc, Guangyao Lvb, Yungang Luc, Qingjun Zhoud, Hui Zhoud, Xiaodong Zengd, Jingwen Zhangb, Chunhong Yanb, Jiacheng Lind, Huai-Rong Luoe, Zixing Dengd, Yuling Xiaod, Jinbin Tianc, Michael X. Zhuc, Xuechuan Honga,d,∗
a State Key Laboratory of Virology, Key Laboratory of Combinatorial Biosynthesis and Drug Discovery (MOE), Medical College, Tibet University, Lasa, China
b Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, China
c Department of Integrative Biology and Pharmacology, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA
d Hubei Province Engineering and Technology Research Center for Fluorinated Pharmaceuticals, Wuhan University School of Pharmaceutical Sciences, Wuhan, China
e Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming, China
1 These authors contributed equally to this article.
10.1016/j.canlet.2018.05.041
Anhui Province Academy of Science and Technology, No. 128,Wanshui Road, Hi-Tech Zone, Hefei City, Anhui Province, China
+86 17354022649
service@sondii.com
IPv6 network supported
Our hours
Beijing time: 9:00-18:00
